AAAAAA
Results:
1-7
|
Results: 7
Authors:
Bersoff-Matcha, SJ
Miller, WC
Aberg, JA
van der Horst, C
Hamrick, HJ
Powderly, WG
Mundy, LM
Citation: Sj. Bersoff-matcha et al., Sex differences in nevirapine rash, CLIN INF D, 32(1), 2001, pp. 124-129
Authors:
Chin-Hong, PV
Sutton, DA
Roemer, M
Jacobson, MA
Aberg, JA
Citation: Pv. Chin-hong et al., Invasive fungal sinusitis and meningitis due to Arthrographis kalrae in a patient with AIDS, J CLIN MICR, 39(2), 2001, pp. 804-807
Authors:
Dube, MP
Sprecher, D
Henry, WK
Aberg, JA
Torriani, FJ
Hodis, HN
Schouten, J
Levin, J
Myers, G
Zackin, R
Nevin, T
Currier, JS
Citation: Mp. Dube et al., Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group, CLIN INF D, 31(5), 2000, pp. 1216-1224
Authors:
Sanchez, JL
Aberg, JA
Citation: Jl. Sanchez et Ja. Aberg, Prophylaxis against fungal infections and cytomegalovirus disease after bone marrow transplantation - The Wilkin/Feinberg article reviewed, ONCOLOGY-NY, 14(12), 2000, pp. 1708
Authors:
Currier, JS
Williams, PL
Koletar, SL
Cohn, SE
Murphy, RL
Heald, AE
Hafner, R
Bassily, EL
Lederman, HM
Knirsch, C
Benson, CA
Valdez, H
Aberg, JA
McCutchan, JA
Citation: Js. Currier et al., Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count - A randomized, double-blind, placebo-controlled trial, ANN INT MED, 133(7), 2000, pp. 493-503
Authors:
Aberg, JA
Citation: Ja. Aberg, Prophylaxis of opportunistic infections in the era of potent antiretroviral therapy: an update, FORMULARY, 34(5), 1999, pp. 418
Authors:
Aberg, JA
Mundy, LM
Powderly, WG
Citation: Ja. Aberg et al., Pulmonary cryptococcosis in patients without HIV infection, CHEST, 115(3), 1999, pp. 734-740
Risultati:
1-7
|